As of August 23, 2019, Hanzhong, Shaanxi province housed 10,073 valid trademark registrations, proclaiming its membership of the 10,000 club.
The Receiving Branch of Trademark Office of CNIPA in Taizhou has received 6,682 trademark registration applications since being operational in July 2016, on top of 1,717 registrations for pledging a trademark as collateral, which is 33% of the nation total.
As of August 30 this year, the Receiving Branch of Trademark Office of CNIPA in Chengdu had received 31,669 applications for trademark registration, 10,004 of which were received online.
Beijing has implemented the Regulations on Rapid Resolution of Patent Infringement Disputes in E-Commerce Sector in Beijing (Trail) since September 1, requiring conclusion of cases within 45 days from admission, and for cases called for extension due to complexity, another 15 days tops.
The evolving nature of China's biotech industry, especially when it comes to the "biologic" drugs has become a hotbed of cancer therapy innovation. About half of the biggest, global biopharma IPOs last year occurred in China. This presents a major shift for China. In the past, China, traditionally, had been much more focused on the generic market. That's changing. They want to go from becoming just a manufacturer to a true innovator.
——How China Is Transforming the Biotech Industry: Brainstorm Health, by Fortune
Chinese companies must attach importance to patent protection, so as to achieve breakthrough in biotechnology sector, which not only gives a good protection for IPR-reliant products, but also effectively competes with domestic and foreign competitors.